Clinical Trial Update: Portal Inflow Modulation Prior to Liver Transplantation in Patients With Increased Risk of Intraoperative Blood Loss [NA]

View source ↗

Summary

Clinical trial evaluating portal inflow modulation before liver transplantation in patients with liver cirrhosis and portal hypertension; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis
• Portal Hypertension

Snippet

Sponsor: Medical University of Warsaw | Conditions: Liver Cirrhosis, Clinically Significant Portal Hypertension | NA | Status: RECRUITING